Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
Authors
Keywords
Schizophrenia, Olanzapine, Aripiprazole, Paliperidone, Paliperidone Palmitate
Journal
CNS DRUGS
Volume 27, Issue 8, Pages 637-652
Publisher
Springer Nature
Online
2013-06-18
DOI
10.1007/s40263-013-0083-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
- (2012) Michael M. Witte et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres
- (2012) Nancy H. Covell et al. JOURNAL OF CLINICAL PSYCHIATRY
- Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years
- (2012) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
- (2012) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
- (2011) Haya Ascher-Svanum et al. BMC Psychiatry
- Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
- (2011) Cynthia A Bossie et al. BMC Psychiatry
- Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
- (2011) Wayne Macfadden et al. BMC Psychiatry
- Long-term remission in schizophrenia and related psychoses with long-acting risperidone: Results obtained in an open-label study with an observation period of 18 months
- (2011) P.-M. Llorca et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Bone Remodeling, Bone Mass and Weight Gain in Patients with Stabilized Schizophrenia in Real-Life Conditions Treated with Long-Acting Injectable Risperidone
- (2011) Mirjana Doknic et al. NEUROENDOCRINOLOGY
- Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
- (2011) Robert A. Rosenheck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
- (2011) Huafang Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone
- (2011) Jennifer Kern Sliwa et al. SCHIZOPHRENIA RESEARCH
- Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
- (2011) George Bartzokis et al. SCHIZOPHRENIA RESEARCH
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)
- (2011) Lamiae Grimaldi-Bensouda et al. SCHIZOPHRENIA RESEARCH
- Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
- (2011) Larry Alphs et al. Annals of General Psychiatry
- Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
- (2011) Tim Lambert et al. Annals of General Psychiatry
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
- (2010) Holland C Detke et al. BMC Psychiatry
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
- (2010) David P McDonnell et al. BMC Psychiatry
- Comparative Effectiveness of Long-Acting Risperidone in New Zealand
- (2010) Christopher Carswell et al. CLINICAL DRUG INVESTIGATION
- Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia
- (2010) H. Ascher-Svanum et al. EUROPEAN PSYCHIATRY
- Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome
- (2010) Keith Lloyd et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders
- (2010) Eduard Parellada et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
- (2010) Srihari Gopal et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Dose correspondence between olanzapine long-acting injection and oral olanzapine
- (2010) Holland C. Detke et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
- (2010) An Thyssen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder
- (2010) Donald C. Goff et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
- (2010) Gahan J. Pandina et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Premorbid Functioning and Treatment Response in Recent-Onset Schizophrenia
- (2010) Jonathan Rabinowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication
- (2010) Simon A Surguladze et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
- (2010) Henry A Nasrallah et al. NEUROPSYCHOPHARMACOLOGY
- Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
- (2010) Wolfgang Gaebel et al. NEUROPSYCHOPHARMACOLOGY
- Does Oral Antipsychotic Pre-Treatment Influence Outcome of a Switch to Long-Acting Injectable Risperidone in Patients with Schizophrenia?
- (2010) M. Schmauß et al. PHARMACOPSYCHIATRY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use
- (2009) D. Taylor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Second-generation antipsychotic long-acting injections: Systematic review
- (2009) W. Wolfgang Fleischhacker BRITISH JOURNAL OF PSYCHIATRY
- Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia
- (2009) Mahesh N. Samtani et al. CLINICAL PHARMACOKINETICS
- Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)
- (2009) J.M. Olivares et al. EUROPEAN PSYCHIATRY
- Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study
- (2009) Jesús De la Gándara et al. Expert Review of Neurotherapeutics
- Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder
- (2009) Alessandro Rossi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
- (2009) John Lauriello et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Controlled Trial of Long-Acting Injectable Risperidone vs Continuation on Oral Atypical Antipsychotics for First-Episode Schizophrenia Patients
- (2009) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
- (2009) David Hough et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- Intramuscular Aripiprazole
- (2008) Mark Sanford et al. CNS DRUGS
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Olanzapine pamoate: a stick in time?
- (2008) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started